Skip to main content

Advertisement

Table 2 Intracellular cytokines—cell prevalence data

From: Cytokine production pattern of T lymphocytes in neonatal arterial ischemic stroke during the first month of life—a case study

% of parent population   Moderate HIE (n = 17) Severe HIE (n = 11) NAIS (n = 4)
IL-10+ CD8+ / CD8+ 6 h 2.75 (1.19–4.12) 4.19 (1.94–6.91) 1.10 (0.40–1.36) b, p = 0.01
IL-10+ CD4+ / CD4+ 24 h 2.88 (1.56–7.03) 4.52 (3.02–6.59) 9.47 (5.10–20.68) a, p = 0.03
IL-10+ CD8+ / CD8+ 72 h 3.51 (1.85–5.12) 5.30 (2.41–6.08) 1.39 (0.52–2.99) b, p = 0.03
TGF-β + CD49d + CD4+ / CD4+ 1 week 10.54 (4.77–14.28) 10.0 (5.46–15.20) 38.00 (14.93–46.78) a, p = 0.03; b, p = 0.05
TGF-β + CD4+ / CD4+ 1 month 3.51 (1.46–4.47) 3.54 (2.47–6.27) 1.30 (0.54–2.49) b, p = 0.05
IL-17+ CD8+ / CD8+ 6 h 3.89 (5.26–14.40) 2.30 (1.73–4.49) c, p = 0.02 5.04 (4.62–7.68) b, p = 0.03
IFN-γ + CD4+ / CD4+ 72 h 6.40 (3.70–11.80) 6.17 (4.75–13.01) 17.50 (2.74–30.20)
IL-6+ CD8+ /CD8+ 72 h 4.37 (3.26–6.29) 5.63 (2.68–8.80) 8.87 (4.75–10.52)
IL-6+ CD8+ /CD8+ 1 month 4.02 (2.40–10.74) 3.70 (2.31–6.16) 4.47 (2.88–8.33)
  1. The prevalence of T cells expressing various cytokines are shown as the percentage of the parent population